SOPHARMA
The computed 12-month bankruptcy probability of SOPHARMA is 0.5% (very low). The company has been active since 2001 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 24 yrs |
| Locations | 1 |
| Publications | 5 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2024 | verkort | 26-05-2025 | 2025-00109479 |
| 31-12-2023 | verkort | 25-06-2024 | 2024-00171990 |
| 31-12-2022 | verkort | 14-06-2023 | 2023-00131367 |
| 31-12-2021 | verkort | 30-09-2022 | 2022-20447461 |
| 31-12-2020 | verkort | 31-08-2021 | 2021-62700035 |
| 31-12-2019 | verkort | 06-07-2020 | 2020-26900464 |
| 31-12-2018 | verkort | 19-07-2019 | 2019-36600450 |
| 31-12-2017 | verkort | 28-08-2018 | 2018-51300485 |
| 31-12-2016 | verkort | 12-07-2017 | 2017-30200311 |
| 31-12-2015 | verkort | 22-08-2016 | 2016-45300019 |
| NACE primary | Retail trade(47730) |
| Legal form | Public limited company(014) |
| Incorporation | 20-12-2001 |
| Status | Active |
| Postal code | 3080 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24302F0048/00V003 | Flanders | 359 m² | 1 · 225 m² | 12.4 m · 3 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
22-07-2025 Discharge granted to the board
Technical details
{
"events": [
{
"kind": "decharge_granted",
"role": "bestuurder",
"person": null,
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "De enige aandeelhouder bevestigt dat zij kosteloos een afschrift van deze verslagen ontvangen heeft en ontslaat de voorzitter van de voorlezing ervan.",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "substantive_delegation",
"role": "bestuurder",
"person": null,
"reason": null,
"subkind": null,
"via_org": {
"kbo": "0451.657.041",
"name": "Moore Finance \u0026 Tax",
"address": "Buro \u0026 Design Center, Esplanade 1 bus 96, 1020 Brussel",
"country": "BE",
"legal_form": "BV"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "De vergadering beslist een bijzondere volmacht te verlenen aan \u0022Moore Finance \u0026 Tax\u0022 besloten vennootschap, ingeschreven met ondernemingsnummer 0451.657.041 en gekend bij de Nederlandstalige Ondernemingsrechtbank Brussel, met zetel te Buro \u0026 Design Center, Esplanade 1 bus 96, 1020 Brussel, alsook aa",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": "Frank De Raedt",
"firm_city": null,
"firm_name": null,
"office_city": "Lievegem",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2025-07-22",
"filing_date": "2025-07-11",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "buitengewone_algemene_vergadering",
"date": "2025-06-30",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0476.391.546",
"name_full": "SOPHARM\u0410",
"legal_form": "NV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Frank De Raedt",
"org_rep_person_name": null,
"person_role_at_subject": "notaris"
},
"co_filed_documents": [
"Expeditie van de akte statutenwijziging",
"Co\u00F6rdinatie van de statuten",
"Bijzonder verslag bestuursorgaan",
"Verslag enige bestuurder",
"Verslag bedrijfsrevisor",
"Onderhandse volmacht"
],
"corrected_publication_numac": null
}22-07-2025 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": "completed",
"notary": {
"name": "Frank De Raedt",
"firm_city": null,
"firm_name": null,
"office_city": "Lievegem",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2025-07-22",
"filing_date": "2025-07-11",
"act_kind_objet": "Fusie door overneming"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2025-06-30",
"unanimous": null
},
"conversion": null,
"detected_kind": "merger_absorption",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0476.391.546",
"name": "SOPHARM\u0410",
"role": "acquiring",
"address": "Jezus Eiklaan 2A, 3080 Tervuren",
"is_foreign": false,
"legal_form": "Naamloze Vennootschap",
"is_new_company": false,
"jurisdiction_country": "BE"
},
{
"kbo": null,
"name": "SOLOBA",
"role": "absorbed",
"address": null,
"is_foreign": false,
"legal_form": "Naamloze Vennootschap",
"is_new_company": false,
"jurisdiction_country": "BE"
}
],
"exchange_ratio": null,
"legal_articles": [
"12:51",
"12:50",
"12:7",
"12:50",
"12:58"
],
"is_cross_border": false,
"is_silent_merger": true,
"balance_basis_date": "2024-12-31",
"exchange_ratio_text": null,
"new_shares_issued_n": null,
"real_estate_included": true,
"patrimony_description": "Het gehele vermogen, zowel de rechten als de verplichtingen, van de overgenomen vennootschap gaat over naar de overnemende vennootschap, inclusief haar activiteiten, vergunningen, merken, goodwill, organisatie, boekhouding en alle immateri\u00EBle en materi\u00EBle bestanddelen.",
"equity_transferred_eur": null,
"accounting_effective_date": "2025-01-01"
},
"subject_company": {
"kbo": "0476.391.546",
"name_full": "SOPHARM\u0410",
"legal_form": "Naamloze Vennootschap"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Frank De Raedt",
"org_rep_person_name": null
},
"summary_narrative": "De naamloze vennootschap SOPHARM\u0410 heeft een fusie door overneming goedgekeurd met de naamloze vennootschap SOLOBA. Het gehele vermogen van SOLOBA gaat over naar SOPHARM\u0410, die de enige aandeelhouder is. De overgenomen vennootschap wordt zonder vereffening opgeheven. De overdracht omvat het volledige vermogen, inclusief onroerende goederen en immateri\u00EBle rechten, en geschiedt zonder kapitaalverhoging.",
"co_filed_documents": [
"Expeditie van de akte fusie door overneming",
"Geco\u00F6rdineerde statuten",
"Onderhandse volmacht"
],
"detected_real_type": "fusion_completed",
"referenced_correction": null,
"should_reroute_to_category": null
}22-07-2025 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": "completed",
"notary": {
"name": "Frank De Raedt",
"firm_city": null,
"firm_name": null,
"office_city": "Lievegem",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2025-07-22",
"filing_date": "2025-07-11",
"act_kind_objet": "Fusie door overneming"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2025-06-30",
"unanimous": null
},
"conversion": null,
"detected_kind": "merger_absorption",
"report_waiver": {
"summary": "De algemene vergadering beslist dat de artikelen 12:25 en 12:26 van het Wetboek van vennootschappen en verenigingen niet worden toegepast, wat een verzaking inhoudt aan het opmaken van het bijzonder verslag van de raad van bestuur en van het verslag van de commissaris, bedrijfsrevisor of gecertifice",
"articles": [
"12:25",
"12:26"
]
},
"restructuring": {
"parties": [
{
"kbo": "0476.391.546",
"name": "SOPHARM\u0410",
"role": "acquiring",
"address": "Jezus Eiklaan 2A, 3080 Tervuren",
"is_foreign": false,
"legal_form": "Naamloze Vennootschap",
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": null,
"name": "EXCELSUS",
"role": "absorbed",
"address": null,
"is_foreign": false,
"legal_form": "Naamloze Vennootschap",
"is_new_company": false,
"jurisdiction_country": null
}
],
"exchange_ratio": 0.3023763,
"legal_articles": [
"12:25",
"12:26",
"12:27",
"12:28",
"12:24",
"3:77 \u00A7 2"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": "2024-12-31",
"exchange_ratio_text": null,
"new_shares_issued_n": 3047,
"real_estate_included": false,
"patrimony_description": "Het gehele vermogen, zowel de rechten als verplichtingen, van de naamloze vennootschap \u0022EXCELSUS\u0022 wordt overgedragen aan de naamloze vennootschap \u0022SOPHARMA\u0022.",
"equity_transferred_eur": 92143353.55,
"accounting_effective_date": "2025-01-01"
},
"subject_company": {
"kbo": "0476.391.546",
"name_full": "SOPHARM\u0410",
"legal_form": "Naamloze Vennootschap"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Frank De Raedt",
"org_rep_person_name": null
},
"summary_narrative": "De naamloze vennootschap SOPHARMA heeft een fusie door overneming goedgekeurd met de naamloze vennootschap EXCELSUS. Het gehele vermogen van EXCELSUS wordt overgedragen aan SOPHARMA. De fusie wordt geboekt vanaf 1 januari 2025 en wordt gefinancierd door de uitgifte van 3.047 nieuwe aandelen aan de aandeelhouder van EXCELSUS, met een boekhoudkundige waarde van \u20AC92.143.353,55.",
"co_filed_documents": [
"Expeditie van de akte fusie door overneming",
"Geco\u00F6rdineerde statuten",
"Bijzonder verslag",
"Onderhandse volmacht",
"Verslag bedrijfsrevisor"
],
"detected_real_type": "fusion_completed",
"referenced_correction": null,
"should_reroute_to_category": null
}26-05-2025 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": "proposal",
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": "Tervuren",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2025-05-26",
"filing_date": "2025-05-16",
"act_kind_objet": "Neerlegging fusievoorstel"
},
"decision": {
"body": null,
"act_date": "2025-05-16",
"unanimous": null
},
"conversion": null,
"detected_kind": "merger_absorption",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0882.189.264",
"name": "SOLOB\u0410",
"role": "absorbed",
"address": "Jan Van Boendalelaan 7, 3080 Tervuren",
"is_foreign": false,
"legal_form": "naamloze vennootschap",
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": "0476.391.546",
"name": "SOPHARMA",
"role": "acquiring",
"address": "Jezus Eiklaan 2A, 3080 Tervuren",
"is_foreign": false,
"legal_form": "naamloze vennootschap",
"is_new_company": false,
"jurisdiction_country": null
}
],
"exchange_ratio": null,
"legal_articles": [
"12:7",
"12:50"
],
"is_cross_border": false,
"is_silent_merger": true,
"balance_basis_date": "2024-12-31",
"exchange_ratio_text": null,
"new_shares_issued_n": null,
"real_estate_included": true,
"patrimony_description": "De totaliteit van het vermogen, de rechten en verplichtingen van de Over Te Nemen Vennootschap SOLOBA zal worden overgenomen door de Verkrijgende Vennootschap SOPHARMA.",
"equity_transferred_eur": null,
"accounting_effective_date": "2025-01-01"
},
"subject_company": {
"kbo": "0476.391.546",
"name_full": "SOLOB\u0410",
"legal_form": "naamloze vennootschap",
"_kbo_extracted_mismatch": "0882.189.264"
},
"publication_proxy": {
"kind": "org",
"org_kbo": "0874.495.976",
"org_name": "CONCELLENT NV",
"person_name": null,
"org_rep_person_name": "Mevr. Sofie Boone"
},
"summary_narrative": "De bestuursorganen van de vennootschappen SOLOB\u0410 en SOPHARMA hebben een fusievoorstel vastgesteld voor een geruisloze fusie. Hierbij wordt het gehele vermogen van SOLOB\u0410 overgenomen door SOPHARMA zonder uitgifte van nieuwe aandelen. De fusie zal worden goedgekeurd door de buitengewone algemene vergaderingen van beide vennootschappen.",
"co_filed_documents": [
"Illustratieve fusiebalans per 31/12/2024"
],
"detected_real_type": "fusion_proposal",
"referenced_correction": null,
"should_reroute_to_category": null
}26-05-2025 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": "proposal",
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": "Tervuren",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2025-05-26",
"filing_date": "2025-05-16",
"act_kind_objet": "Neerlegging fusievoorstel"
},
"decision": {
"body": null,
"act_date": "2025-05-16",
"unanimous": null
},
"conversion": null,
"detected_kind": "merger_absorption",
"report_waiver": {
"summary": "De enige aandeelhouder van de betrokken vennootschappen heeft de intentie uitgedrukt om af te zien van de controleverslagen en informatieverplichtingen die op de bestuursorganen rusten, zoals voorzien in de artikelen 12:26, 12:25, 12:27, 12:64 en 12:80 WVV.",
"articles": [
"12:26 \u00A71",
"12:25",
"12:27",
"12:64 \u00A72",
"12:80 \u00A72"
]
},
"restructuring": {
"parties": [
{
"kbo": "0886.339.775",
"name": "EXCELSUS",
"role": "absorbed",
"address": "Fochlaan 1, 8300 Knokke-Heist",
"is_foreign": false,
"legal_form": "naamloze vennootschap",
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": "0476.391.546",
"name": "SOPHARMA",
"role": "acquiring",
"address": "Jezus Eiklaan 2A, 3080 Tervuren",
"is_foreign": false,
"legal_form": "naamloze vennootschap",
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": "0882.189.264",
"name": "SOLOBA",
"role": "absorbed",
"address": null,
"is_foreign": false,
"legal_form": null,
"is_new_company": false,
"jurisdiction_country": null
}
],
"exchange_ratio": 1.0,
"legal_articles": [
"12:2",
"12:24",
"12:25",
"12:26",
"12:27",
"12:28",
"3:77"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": "2024-12-31",
"exchange_ratio_text": null,
"new_shares_issued_n": 3047,
"real_estate_included": false,
"patrimony_description": "De totaliteit van het vermogen, zowel de rechten als de verplichtingen, van de Over Te Nemen Vennootschap zal worden overgedragen aan de Verkrijgende Vennootschap.",
"equity_transferred_eur": 92143353.55,
"accounting_effective_date": "2025-01-01"
},
"subject_company": {
"kbo": "0476.391.546",
"name_full": "SOPHARMA",
"legal_form": "Naamloze vennootschap"
},
"publication_proxy": {
"kind": "org",
"org_kbo": "0874.495.976",
"org_name": "CONCELLENT NV",
"person_name": null,
"org_rep_person_name": "Sofie Boone"
},
"summary_narrative": "De bestuursorganen van de vennootschappen EXCELSUS en SOPHARMA hebben een fusievoorstel opgesteld voor een fusie door overneming. Hierbij wordt het gehele vermogen van EXCELSUS overgedragen aan SOPHARMA. De fusie is ingegeven vanuit zakelijke overwegingen om de vennootschapsstructuur te vereenvoudigen en te rationaliseren. De verrichting zal boekhoudkundig en fiscaal worden verwerkt vanaf 1 januari 2025.",
"co_filed_documents": [
"Illustratieve fusiebalans per 31/12/2024"
],
"detected_real_type": "fusion_proposal",
"referenced_correction": null,
"should_reroute_to_category": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | SOPHARMA |